Figure 3 :A) Atypical lymphoid cells from the breast lesion (H and E; x 200) B) Negati ve immuno staining for Cytokerati n (DAB; x 200) C) Negati ve immuno straining for CD 3 anti gen (DAB; x200) D) CD 20 immuno stain showing crisp membrane positi vity of tumor cell (DAB; x200)